Please assess the completion status of the following clinical trial:

Trial Title: Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy adolescents and pre-adolescents with no prior sexual history~* Healthy women who have an intact uterus with lifetime history of 0-4 sexual partners~Exclusion Criteria:~* Prior Human Papillomavirus (HPV) vaccination~* Prior abnormal Paps~* Prior history of genital warts

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: 23 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): 100% Formulation qHPV Vaccine
- 2 (Type: EXPERIMENTAL): 60% Formulation qHPV Vaccine
- 3 (Type: EXPERIMENTAL): 40% Formulation qHPV Vaccine
- 4 (Type: EXPERIMENTAL): 20% Formulation qHPV Vaccine

Based on this trial design, predict the completion outcome and termination type (if applicable).